1. Home
  2. HOVR vs MNOV Comparison

HOVR vs MNOV Comparison

Compare HOVR & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Horizon Aircraft Ltd.

HOVR

New Horizon Aircraft Ltd.

HOLD

Current Price

$1.74

Market Cap

80.6M

Sector

Finance

ML Signal

HOLD

Logo Medicinova Inc

MNOV

Medicinova Inc

HOLD

Current Price

$1.38

Market Cap

67.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOVR
MNOV
Founded
2013
2000
Country
Canada
United States
Employees
30
6
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
80.6M
67.9M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
HOVR
MNOV
Price
$1.74
$1.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$10.33
$7.50
AVG Volume (30 Days)
1.1M
72.5K
Earning Date
04-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,360,807.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$180.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
194.15
52 Week Low
$1.16
$1.17
52 Week High
$4.18
$1.96

Technical Indicators

Market Signals
Indicator
HOVR
MNOV
Relative Strength Index (RSI) 36.24 54.63
Support Level $1.72 $1.31
Resistance Level $1.91 $1.52
Average True Range (ATR) 0.13 0.06
MACD -0.02 0.01
Stochastic Oscillator 11.97 43.54

Price Performance

Historical Comparison
HOVR
MNOV

About HOVR New Horizon Aircraft Ltd.

New Horizon Aircraft Ltd is an aerospace Original Equipment Manufacturer that is designing and building a next-generation hybrid electric vertical take-off and landing aircraft for the regional air mobility market. Its aircraft will offer a more efficient way to move people and goods at a regional scale, help to connect remote communities, and advance its ability to deal with an increasing number of climate-related natural disasters such as wildfires, floods, and droughts. The company aims to deliver a hybrid electric 7-seat aircraft, called the Cavorite X7, that can take off and land vertically like and helicopter.

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

Share on Social Networks: